Malaysia Compare Sinovac Vs Pfizer Vs AstraZeneca Vaccine, Here Are The Results


Malaysia conducted a study to reveal the effectiveness vaksin Sinovac, Pfizer and AstraZeneca against COVID-19. All three are said to offer good protection to prevent COVID-19.

Quoted from Reuters, the study stated that the Sinovac vaccine was very effective in preventing severe and serious symptoms, although its efficacy was lower than Pfizer and AstraZeneca.

A study conducted by the Malaysian government found that 0.011 percent of the approximately 7.2 million Sinovac vaccine recipients were admitted to the intensive care unit (ICU) for COVID-19 infection.

Meanwhile, 0.002 percent of Pfizer’s approximately 6.5 million vaccine recipients require ICU care for COVID-19 infection. For the AstraZeneca vaccine, there were 0.001 percent of the 744,958 recipients admitted to the ICU.

Kalaiarasu Peariasamy, director at the Institute for Clinical Research who conducted the study together with the national COVID-19 task force, said vaccination, regardless of brand, had reduced the risk of admission to intensive care by 83 percent and lowered the risk of death.

“The breakthrough rate for intensive care units is very low,” he said, adding overall ICU admissions among fully vaccinated individuals stood at 0.0066 percent.

The mortality rate of fully vaccinated people is also low at 0.01 percent and the majority of them are over 60 years old or with comorbidities.

“There are demographic differences between the recipients of the three vaccines and that can produce different results,” said Kalaiarasu.

Many AstraZeneca recipients are in “middle adulthood”, while Pfizer and Sinovac vaccines are administered to vulnerable populations.

In July, Malaysia said it would stop administering the Sinovac vaccine once supplies run out, as it has enough other vaccines for its programme.

See also  Özlem Türeci and Uğur Şahin, who developed a coronavirus vaccine, announced their new goals

Sinovac’s vaccine is already in widespread use in several countries including China, Indonesia, Thailand and Brazil, and the company said earlier this month it had supplied 1.8 billion doses at home and abroad.

Watch Videos”Singapore Officially Uses Pfizer Vaccine for Teens 12-15 Years Old
[Gambas:Video 20detik]
(kna / kna)


Leave a Comment